Legal Opinion

Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC

District Court, D. Delaware

Decided September 3, 2021No. 1:18-cv-00699Unknown

1Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE NOVEN PHARMACEUTICALS, INC., : Plaintiff, □ Vv. C.A. No. 18-699-LPS AMNEAL PHARMACEUTICALS LLC, □ Defendant. MEMORANDUM ORDER At Wilmington this day of September, 2021: Pending before the Court is Defendant Amneal Pharmaceuticals LLC’s (“Amneal”) motion for attorneys’ fees filed pursuant to 35 U.S.C. § 285. (D.I. 232) Having reviewed the parties’ briefs, declarations, exhibits, and notice of subsequent authority (see, e.g., D-I. 233-34, 238-39, 243, 247), and having heard the parties’ argument during the teleconference on April…

2Cases cited6 opinions

  1. Octane Fitness, LLC v. Icon HealthSupreme Court of the United States · 2014
  2. Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.Court of Appeals for the Federal Circuit · 2010
  3. Nuvo Pharm. (Ireland) Designated Activity Co. v. Dr. Reddy's Labs. Inc.Court of Appeals for the Federal Circuit · 2019
  4. Amgen Inc. v. Sanofi, Aventisub LLCCourt of Appeals for the Federal Circuit · 2017
  5. Chrimar Systems, Inc. v. Foundry Networks, Inc.District Court, E.D. Michigan · 2013

1 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API